Sanofi-Regeneron's arthritis drug sarilumab enters late-stage trials

05/15/2013 | Yahoo

Sanofi and Regeneron Pharmaceuticals have started enrolling patients with moderate to severe rheumatoid polyarthritis for two late-stage trials of their experimental drug sarilumab. The partners intend to recruit 2,600 patients.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ